Neuberger Berman Group LLC - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 93 filers reported holding CYTOSORBENTS CORP in Q4 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
Neuberger Berman Group LLC ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q3 2023$2,821,112
-47.2%
1,502,696
+0.9%
0.00%
-40.0%
Q2 2023$5,344,236
+2.1%
1,488,645
-3.8%
0.01%0.0%
Q1 2023$5,232,629
+124.8%
1,547,923
+1.2%
0.01%
+150.0%
Q4 2022$2,327,445
+16.2%
1,529,095
+3.3%
0.00%0.0%
Q3 2022$2,003,000
-31.4%
1,479,570
+11.4%
0.00%
-33.3%
Q2 2022$2,918,000
-26.7%
1,328,270
+6.1%
0.00%0.0%
Q1 2022$3,980,000
-24.3%
1,251,812
-0.3%
0.00%
-25.0%
Q4 2021$5,259,000
-48.5%
1,256,068
-0.4%
0.00%
-55.6%
Q3 2021$10,203,000
+59.6%
1,260,574
+48.8%
0.01%
+50.0%
Q2 2021$6,394,000
-14.4%
847,089
-1.9%
0.01%
-14.3%
Q1 2021$7,471,000
+2.8%
863,814
-5.4%
0.01%
-12.5%
Q4 2020$7,270,000
+56.5%
913,149
+56.7%
0.01%
+33.3%
Q3 2020$4,645,000582,5940.01%
Other shareholders
CYTOSORBENTS CORP shareholders Q4 2021
NameSharesValueWeighting ↓
CM Management, LLC 450,000$1,6161.58%
Skylands Capital, LLC 2,793,470$10,028,5571.44%
Sargent Investment Group, LLC 1,289,546$4,629,4701.12%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 237,940$854,2050.96%
Avenir Corp 2,719,732$9,763,8380.86%
Granahan Investment Management 1,616,587$5,803,5470.18%
Seelaus Asset Management LLC 20,450$730.06%
Cowen Prime Advisors LLC 42,301$151,8610.05%
HighMark Wealth Management LLC 10,000$35,9000.03%
Key Client Fiduciary Advisors, LLC 12,000$43,0800.02%
View complete list of CYTOSORBENTS CORP shareholders